Online citations, reference lists, and bibliographies.
← Back to Search

Eyelid Movement Abnormalities In Progressive Supranuclear Palsy

Lawrence I. Golbe, Frederick E. Lepore, Patricia H. Davis
Published 1989 · Psychology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
We systematically videotaped eyelid movements in a community‐based series of 38 patients with progressive supranuclear palsy (PSP). Ten patients (26%) had blepharospasm, “apraxia” of lid opening and/or “apraxia” of lid closing. These patients as a group had more severe upgaze paresis but no greater disease duration than the patients without supranuclear lid dysfunction. Patients used a variety of synkinetic movements to overcome lid‐movement abnormalities. One patient displayed “slow blinks”, a phenomenon not previosly described in PSP. Blink rate in PSP, 3.0/min, was markedly lower than that in patients with Parkinson's disease (PD), 12.5/min, and patients with PSP but not PD increased their blink rate during command versional eye movements.
This paper references
10.1212/WNL.33.9.1237
Blepharospasm associated with brainstem lesions
J. Jankovic (1983)
10.1093/BRAIN/111.2.267
Orienting of visual attention in progressive supranuclear palsy.
R. Rafal (1988)
10.1016/0002-9394(72)90740-4
Ocular manifestations in progressive supranuclear palsy.
D. Pfaffenbach (1972)
10.1212/WNL.35.3.423
“Apraxia” of eyelid opening
F. E. Lepore (1985)
10.1212/WNL.18.4.349
Further observations in progressive supranuclear palsy
N. J. David (1968)
10.1212/WNL.33.9.1233
Blink‐saccade synkinesis
D. Zee (1983)
10.1001/ARCHNEUR.1964.00460160003001
PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.
J. Steele (1964)
10.1002/MDS.870030305
Pathological report of four patients presenting with cranial dystonias
W. Gibb (1988)
10.1016/0014-2999(84)90238-3
[3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy.
B. Bokobza (1984)
10.1212/WNL.34.5.677
Blink rates and disorders of movement
C. Karson (1984)
10.1001/ARCHOPHT.1967.00980020611009
Ocular signs from brain stimulation and lesions.
B. Nashold (1967)
10.1002/ANA.410170406
Atypical presentation of progressive supranuclear palsy
P. Davis (1985)
10.1212/WNL.38.10.1546
Risk factors for progressive supranuclear palsy
P. Davis (1988)
10.1212/WNL.36.7.1005
The clinical features and natural history of the Steele‐Richardson‐Olszewski syndrome (progressive supranuclear palsy)
E. Maher (1986)
10.1002/ANA.410130308
Progressive supranuclear palsy: Clinical features and response to treatment in 16 patients
J. A. Jackson (1983)
10.1056/NEJM197508142930710
Case 32-1975
E. Picard (1975)
10.1212/WNL.38.7.1031
Prevalence and natural history of progressive supranuclear palsy
L. Golbe (1988)
10.1159/000152153
Genetical and Population-Genetical Investigations on β-Lipoprotein Polymorphism
W. K. Wassenich (1968)



This paper is referenced by
10.1002/MDS.870120221
Inability to close eyelids as a feature of palpebral dystonia
P. Krack (1997)
10.1136/jnnp.62.4.352
Dystonia in progressive supranuclear palsy.
C. Barclay (1997)
10.1007/S12603-010-0007-Z
Neurodegenerative dementia and Parkinsonism
A. Gabelle (2010)
10.1007/978-1-59259-410-8_16
Progressive Supranuclear Palsy
M. Stacy (2000)
Classic diseases revisited Progressive supranuclear palsy ( Steele-Richardson-Olszewski disease )
Huw R. Morris (1999)
10.1016/S1567-424X(09)70073-X
Neurophysiological aids to the diagnosis of progressive supranuclear palsy (PSP).
J. Valls-Solé (2006)
10.1007/978-3-7091-1516-9_7
Dystonia in Multiple System Atrophy, Progressive Supranuclear Palsy, and Corticobasal Degeneration
Luca Marsili (2015)
10.1002/MDS.870120651
Apraxia of eyelid closure accompanied by denial of eye opening
M. Aramideh (1997)
10.1016/S0733-8619(05)70037-2
Lumping and splitting the Parkinson Plus syndromes: dementia with Lewy bodies, multiple system atrophy, progressive supranuclear palsy, and cortical-basal ganglionic degeneration.
M. Mark (2001)
10.18821/1560-9545
Поражение периферических нервов паранеопластического и токсического генеза у пациентов, страдающих раком молочной железы и мелкоклеточным раком легкого
Array С. Королева (2013)
10.1016/S0008-4182(06)80015-3
Intermittent reversal of complete ptosis associated with sphenoid wing meningiomas.
R. Egan (2006)
10.1055/s-0034-1381736
Progressive supranuclear palsy.
L. Golbe (2014)
10.3389/fneur.2017.00329
Eyelid Dysfunction in Neurodegenerative, Neurogenetic, and Neurometabolic Disease
A. Hamedani (2017)
10.1002/MDS.870090404
Clinical and electromyographic features of levator palpebrae superioris muscle dysfunction in involuntary eyelid closure
M. Aramideh (1994)
10.1523/JNEUROSCI.6218-10.2011
Characterizing the Spontaneous Blink Generator: An Animal Model
Jaime Kaminer (2011)
10.1007/978-1-4614-4466-4
Craniofacial Muscles
L. McLoon (2013)
10.1017/9781139924771.015
The cognitive neurology of corticobasal degeneration and progressive supranuclear palsy
C. Fredericks (2016)
10.1093/SCHBUL/16.2.345
Blink rates in schizophrenia.
C. Karson (1990)
10.1002/MDS.870080420
What is it? Case 1, 1993: Parkinsonism, dysautonomia, and ophthalmoparesis
J. Jankovic (1993)
10.1111/j.1532-5415.1994.tb06858.x
Blinking and the Release Reflexes: Are They Clinically Useful?
R. Thomas (1994)
10.1007/s007020200016
Apraxia of eyelid closure in Huntington's disease
R. Bonelli (2002)
10.1016/S1634-7072(07)70558-5
Paralisi sopranucleare progressiva (malattia di Steele-Richardson-Olszewski)
F. Dubas (2007)
10.1016/S0246-0378(06)29334-5
Paralysie supranucléaire progressive (maladie de Steele-Richardson-Olszewski)
F. Dubas (2006)
10.1186/s40035-019-0160-1
How to spot ocular abnormalities in progressive supranuclear palsy? A practical review
Onanong Phokaewvarangkul (2019)
10.1212/WNL.48.6.1491
Apraxia of lid opening
D. Boghen (1997)
10.1002/MDS.870090605
“Apraxia of lid opening,” a focal eyelid dystonia: Clinical study of 32 patients
P. Krack (1994)
10.1002/ame2.12097
Epalrestat improves motor symptoms by reducing oxidative stress and inflammation in the reserpine induced mouse model of Parkinson’s disease
M. Rahman (2020)
10.1016/j.neucli.2004.01.002
Eyelid movements in health and disease. The supranuclear impairment of the palpebral motility
Ángel Esteban (2004)
10.1212/WNL.45.5.897
Motor persistence of orbicularis oculi muscle in eyelid‐opening disorders
M. Aramideh (1995)
10.1002/MDS.870060222
Proposal for a clinical definition of blepharokolysis
J. Fueyo (1991)
10.1016/S1353-8020(96)00029-6
Akinesia and axial rigidity without limb rigidity: an intermediate form between progressive supranuclear palsy and pure akinesia of Imai and Narabayashi.
Y. Nakajima (1996)
10.1007/978-1-4614-4466-4_16
Spastic Facial Muscle Disorders
Juwan Park (2012)
See more
Semantic Scholar Logo Some data provided by SemanticScholar